MAPT and Alzheimer disease: Although the amyloid cascade hypothesis remains the leading model for AD pathogenesis, it is part of an evolving and sometimes controversial debate; accumulating genetic, pathological, and biomarker evidence still strongly supports amyloid as a major initiating event, while recognizing that tau pathology, neuroinflammation, and other mechanisms act in parallel to drive neurodegeneration.